Vertex Pharmaceuticals research and development expenses for the twelve months ending September 30, 2024 were $3.456B, a 13.98% increase year-over-year.
Vertex Pharmaceuticals annual research and development expenses for 2023 were $3.163B, a 24.51% increase from 2022.
Vertex Pharmaceuticals annual research and development expenses for 2022 were $2.54B, a 31.09% increase from 2021.
Vertex Pharmaceuticals annual research and development expenses for 2021 were $1.938B, a 17.81% increase from 2020.
Vertex Pharmaceuticals Research and Development Expenses 2010-2024 | VRTX